Publishing regularly in Harper's Weekly, the celebrated Nast drew thousands of cartoons during the second half of the nineteenth century. Like many Northerners, Nast supported President Lincoln ...

Political cartoons and drawings were popular features in 1890s newspapers and the yellow journals of the Spanish-American War era. Before the Spanish-American War began, drawings depicting Spain ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

Artists take on 60 surrealist minutes, word salad, and more A free daily email with the biggest news stories of the day – and the best features from TheWeek.com Contact me with news and offers ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.

These drops have been specially developed for people who have presbyopia, an eye-related condition that affects those above ...

The artwork of Mister Cartoon can be seen pretty much everywhere — tattooed on celebrities, exhibited in art galleries, airbrushed on cars, painted on public walls and printed on team jerseys.

The Drugs Controller General of India (DCGI) has granted approval to Entod Pharmaceuticals’ innovative PresVu eye drops, ...

(RTTNews) - LENZ Therapeutics, Inc. (LENZ) Monday said that the Food and Drug Administration (FDA) has accepted the company's new drug application for LNZ100 for the treatment of presbyopia.